Melanoma is the most dangerous form of skin cancer, arising from melanocytes. UV radiation is the primary risk factor; early detection using the ABCDE criteria (Asymmetry, Border, Color, Diameter, Evolution) is critical for survival.
Pembrolizumab is an immune checkpoint inhibitor that unleashes the immune system against cancer cells, used in melanoma, lung cancer, and other malignancies.
Nivolumab is an immune checkpoint inhibitor that unleashes the immune system against cancer cells, used in melanoma, lung cancer, and other malignancies.
Ipilimumab is an immune checkpoint inhibitor that unleashes the immune system against cancer cells, used in melanoma, lung cancer, and other malignancies.
Atezolizumab is an immune checkpoint inhibitor that unleashes the immune system against cancer cells, used in melanoma, lung cancer, and other malignancies.
Describe your symptoms and get a structured AI clinical assessment — possible causes, urgency level, and recommended next steps.
Start Free AI Analysis →Content on this page is informed by evidence-based clinical sources including: